https://www.biospace.com/pdl-biopharma-reschedules-third-quarter-2020-financial-results-and-business-update
PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update - BioSpace
Nov 7, 2020 - PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces it has rescheduled the date for announcing third quarter 2020 financial results and...
pdl biopharmathird quarter2020 financial
https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/pdl-biopharma-public-offering/
PDL BioPharma Prices Public Offering | INN
Jan 7, 2026 - PDL BioPharma (NASDAQ:PDLI) today announces that it will sell $150.0 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2021 in an...
pdl biopharmapublic offeringpricesinn
https://www.prnewswire.com/news-releases/pdl-biopharma-completes-regular-quarterly-dividend-payment-211260501.html
PDL BioPharma Completes Regular Quarterly Dividend Payment
/PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2013, regular quarterly dividend payment of $0.15 per...
pdl biopharmacompletesregularquarterlydividend
https://www.prnewswire.com/news-releases/pdl-biopharma-announces-favorable-decision-in-wellstat-diagnostics-litigation-300916657.html
PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation
/PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that the Supreme Court of New York, County of New York, Commercial...
pdl biopharmaannouncesfavorabledecisiondiagnostics
https://www.fool.com/investing/general/2016/02/23/why-pdl-biopharma-inc-is-up-today.aspx
Why PDL BioPharma Inc is Up Big Today | The Motley Fool
Feb 23, 2016 - Higher than expected fourth-quarter profits has investors seeing green today.
pdl biopharmathe motleyinc
https://www.prnewswire.com/news-releases/pdl-biopharma-completes-distribution-of-evofem-biosciences-common-stock-to-pdl-stockholders-301063876.html
PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders
/PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of...
pdl biopharmacommon stockcompletesdistribution
https://www.biospace.com/pdl-biopharma-inc-provides-first-quarter-2014-revenue-guidance-of-133-million
PDL BioPharma, Inc. Provides First Quarter 2014 Revenue Guidance Of $133 Million - BioSpace
https://www.biospace.com/pdl-biopharma-inc-announces-physician-survey-results-on-heart-attack-treatment-presented-at-american-college-of-emergency-physicians-scientific-asse
PDL BioPharma, Inc. Announces Physician Survey Results On Heart Attack Treatment Presented At...
https://www.biospace.com/pdl-biopharma-declares-distribution-ratio-for-dividend-of-evofem-biosciences-common-stock-to-pdl-stockholders
PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL...
May 19, 2020 - PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the final distribution ratio for the previously announced distribution of all of the...